1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
- 2017
- A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement
- 2015
- Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
- Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
- 2014
- Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
- 2013
- Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
- 2012
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
- Large-scale replication and heterogeneity in Parkinson disease genetic loci
- 2011
- Human leukocyte antigen variation and Parkinson's disease.
- VPS35 Mutations in Parkinson Disease